ArTS Archivio della ricerca di Trieste

CONFALONIERI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.866
NA - Nord America 3.524
EU - Europa 2.878
SA - Sud America 447
AF - Africa 146
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.878
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.375
SG - Singapore 1.318
IT - Italia 974
CN - Cina 835
VN - Vietnam 492
HK - Hong Kong 401
BR - Brasile 337
DE - Germania 278
KR - Corea 264
GB - Regno Unito 224
FR - Francia 210
SE - Svezia 192
NL - Olanda 179
FI - Finlandia 176
PL - Polonia 144
RU - Federazione Russa 115
IN - India 111
IE - Irlanda 69
BG - Bulgaria 60
CA - Canada 60
TR - Turchia 56
MX - Messico 55
JP - Giappone 50
AT - Austria 48
CH - Svizzera 47
MA - Marocco 47
BD - Bangladesh 43
ID - Indonesia 41
IQ - Iraq 36
ES - Italia 34
AR - Argentina 33
UA - Ucraina 32
ZA - Sudafrica 28
PK - Pakistan 24
PH - Filippine 22
SA - Arabia Saudita 22
CO - Colombia 21
BE - Belgio 17
UZ - Uzbekistan 16
EC - Ecuador 15
TH - Thailandia 15
IR - Iran 13
TW - Taiwan 13
CL - Cile 12
EG - Egitto 12
SN - Senegal 12
VE - Venezuela 12
CZ - Repubblica Ceca 11
GR - Grecia 11
AE - Emirati Arabi Uniti 10
AU - Australia 10
IL - Israele 10
MY - Malesia 10
AZ - Azerbaigian 9
TN - Tunisia 9
NP - Nepal 8
PA - Panama 8
RO - Romania 8
AO - Angola 6
CR - Costa Rica 6
DK - Danimarca 6
JO - Giordania 6
KE - Kenya 6
LK - Sri Lanka 6
LT - Lituania 6
OM - Oman 6
PT - Portogallo 6
BY - Bielorussia 5
DZ - Algeria 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
PE - Perù 5
PY - Paraguay 5
AL - Albania 4
HN - Honduras 4
LU - Lussemburgo 4
NG - Nigeria 4
NO - Norvegia 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
YE - Yemen 4
CI - Costa d'Avorio 3
ET - Etiopia 3
HU - Ungheria 3
LY - Libia 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MG - Madagascar 2
QA - Qatar 2
SI - Slovenia 2
AI - Anguilla 1
AM - Armenia 1
BB - Barbados 1
Totale 10.851
Salva come PNG Salva come JPEG
Città #
Singapore 731
Ashburn 513
San Jose 483
Hong Kong 384
Hefei 259
Seoul 259
Chandler 258
Trieste 186
Beijing 181
Council Bluffs 175
Ho Chi Minh City 148
Los Angeles 130
Boardman 117
Hanoi 115
Dallas 109
London 104
Chicago 91
Columbus 82
Lauterbourg 82
Santa Clara 76
Helsinki 70
Lappeenranta 66
Milan 66
Munich 66
Zgierz 66
Frankfurt am Main 64
New York 63
Sofia 58
Warsaw 58
Dublin 57
Princeton 56
Moscow 55
The Dalles 55
São Paulo 46
Turku 36
Tokyo 34
Casablanca 33
Vienna 31
Buffalo 29
Denver 29
Manchester 29
Nuremberg 29
Redmond 29
Amsterdam 28
Rome 28
Montreal 27
Wilmington 27
Bern 25
Dong Ket 25
Haiphong 25
Orem 24
Düsseldorf 23
Atlanta 21
North Bergen 21
Boydton 20
Chennai 20
Shanghai 20
Udine 20
Da Nang 19
Redondo Beach 19
Mexico City 18
Florence 17
Wroclaw 17
Mumbai 16
Paris 16
Turin 16
Baghdad 15
Brussels 15
Rio de Janeiro 15
Ankara 14
Berlin 14
Bremen 14
Pordenone 14
Seattle 14
Tashkent 14
Adana 13
Barnet 13
Toronto 13
Treviso 13
Ann Arbor 12
Dakar 12
Jakarta 12
Johannesburg 12
Naples 12
San Donà di Piave 12
Stockholm 12
Thái Nguyên 12
Woodbridge 12
Brooklyn 11
Guangzhou 11
Houston 11
Phoenix 11
Redwood City 11
Riyadh 11
Zurich 11
Bangkok 10
Dhaka 10
Istanbul 10
Pune 10
Tappahannock 10
Totale 6.516
Salva come PNG Salva come JPEG
Nome #
Alveolar Epithelial Type II Cells 328
Chronic Thromboembolic Pulmonary Hypertension: An Update 209
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung 197
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 197
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 192
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 191
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 185
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 183
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 180
Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud’s Phenomenon 177
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 177
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 176
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? 176
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 175
Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia 174
The Treatment of Lung Involvement in Systemic Sclerosis 170
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria 165
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 163
Deciphering loop gain complexity: a primer for understanding a pathophysiological trait of obstructive sleep apnea patients 162
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) 161
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 159
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 159
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 158
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 151
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 149
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier 148
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients 147
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? 147
Caution When Comparing the Impact of Corticosteroids in COVID-19 143
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients 143
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 141
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS 140
Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings 138
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 138
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 136
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 136
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis 136
Host-Based Treatments for Severe COVID-19 135
Evaluation of Correlations between Genetic Variants and High‐Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 135
Advances in Diagnostics and Management of Respiratory System Diseases 133
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction 132
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study 130
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 129
Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated 127
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial 126
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis 126
Comorbidities’ Effect on IPF: Pathogenesis and Management 126
Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support 125
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 124
Valutazione dei fattori di rischio di embolia polmonare nei pazienti affetti da sarcoidosi 124
Chronic Obstructive Pulmonary Disease definition: is it time to incorporate also the concept of lung regeneration's failure? 124
Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment 123
Autoantibodies in sarcoidosis: innocent bystander or promising biomarker for organ involvement? 122
Oscillometry Longitudinal Data on COVID-19 Acute Respiratory Syndrome Treated with Non-Invasive Respiratory Support 119
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 117
Nailfold Video-Capillaroscopy in Sarcoidosis: New Perspectives and Challenges 117
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity 116
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease 115
Biomarkers in Systemic Sclerosis: An Overview 114
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 113
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant 111
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 106
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 100
Monitoring lung mechanics by oscillometry in COVID 19 ARDS receiving non-invasive ventilation: a pilot study 98
Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis 97
Epithelial-Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis? 88
What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases? 87
Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19 82
Monitoring the microcirculation in the diagnosis and follow-up of systemic sclerosis patients: Focus on pulmonary and peripheral vascular manifestations 82
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 82
Evaluation of Nailfold Capillaroscopy as a Novel Tool in the Assessment of Eosinophilic Granulomatosis with Polyangiitis. 80
The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients 78
Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update 75
Evaluating Nailfold Capillaroscopy as a Diagnostic Tool in EGPA with Pulmonary Involvement 71
Cardiac sarcoidosis recurrence post-heart transplant: A critical literature and case report 67
Risk factor of pulmonary embolism in sarcoidosis patients: a pilot study 63
Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials 62
Early C-reactive protein reduction predicts survival in COVID-19 severe pneumonia treated with glucocorticoids 59
Indirect evaluation of lung condition by means of LF-NMR following chest physiotherapy or ETI administration in cystic-fibrosis patients 58
First evaluation of microvascular damage through nailfold capillaroscopy of an uncommon case of Raynaud's phenomenon in multiple sclerosis: Case report and literature review 56
Exploring sarcoidosis via nailfold capillaroscopy: A window into the disease’s microvascular landscape 54
Retrospective Observational Study of Nintedanib in Managing Idiopathic and Progressive Pulmonary Fibrosis in Routine Practice 53
Evaluation of possible risk factor of pulmonary embolism in sarcoidosis patients 49
Editorial for “Diagnosis, Classification, and Monitoring of Pulmonary Diseases” 47
Formaldehyde vapour fixation enables multiscale phase-contrast imaging and histological validation of human-sized lungs 43
Evaluation of chronic thromboembolic pulmonary hypertension: a pilot-study 41
Analyzing Sarcoidosis via Nailfold Capillaroscopy: Microvascular Insights 38
Existence and relevance of fulminant severe community-acquired pneumonia 36
Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies 35
Trattamenti dell’ipertensione polmonare tromboembolica cronica (CTEPH): uno studio pilota 34
Investigating Fairness with FanFAIR: is Pre-processing Useful Only for Performances? 33
Ultra-high-resolution synchrotron phase-contrast CT enables microstructural pulmonary imaging at clinical dose levels 33
Sex differences in low arousal threshold in obstructive sleep apnea 32
Multinational Survey on the Symptom Approach to Diagnosis and Therapy Adopted by Physicians in the Treatment of Gastrointestinal Sarcoidosis 31
Totale 11.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.986
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 0 0 0 40 8 12
2021/2022489 43 12 28 57 39 13 32 14 72 35 41 103
2022/2023942 79 112 94 90 78 117 29 85 119 24 75 40
2023/20241.074 70 48 81 74 108 92 223 134 39 47 96 62
2024/20252.318 59 129 173 206 187 168 137 127 249 337 234 312
2025/20266.198 603 387 521 723 569 553 945 291 816 790 0 0
Totale 11.220